Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

CD34 marks potential stem cells in dog hair follicles.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Epigenetic changes in blood cells may contribute to alopecia areata.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

c-Maf positive macrophages help form hypertrophic scars by affecting fibroblasts and collagen production.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

Macrophage issues cause chronic wound inflammation, but therapies can help.

Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.

Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Hair follicles help attract immune cells to minor skin injuries.

CDH3-related disease causes worsening eye and hair issues.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Human thymus has stem cells that can self-renew and maintain their identity.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Macrophages help heal nerves by aiding the maturation of Schwann cells and are important for nerve repair.